KYLE OSTROM: Open Payments
NPI 1376746743 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 7 payments from 5 companies in 2025. Trend: 2023 $380 · 2024 $307 · 2025 $178
Food & beverage: $101Education: $77
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $77 |
| Novo Nordisk Inc | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REXULTI, Wegovy, Rybelsus, AIRSUPRA, TZIELD, SHINGRIX.
Industry payments across MO — which companies pay providers there.
